ArticleOrphanet journal of rare diseases2022

Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels.

Mónica Álvarez-Córdoba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.